Yutaka Kohgo Selected Research

Yutaka Kohgo Research Topics

Disease

31	Neoplasms (Cancer) 01/2019 - 07/2002
15	Iron Overload 03/2017 - 08/2002
11	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 04/2002
11	Inflammation (Inflammations) 09/2020 - 09/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2004
8	Stomach Neoplasms (Stomach Cancer) 12/2020 - 07/2002
8	Fibrosis (Cirrhosis) 05/2018 - 08/2003
8	Non-alcoholic Fatty Liver Disease 03/2017 - 03/2008
7	Colitis 08/2015 - 04/2004
6	Carcinogenesis 01/2019 - 04/2008
6	Liver Diseases (Liver Disease) 05/2018 - 04/2002
6	Infections 11/2017 - 11/2006
6	Colonic Neoplasms (Colon Cancer) 01/2017 - 09/2005
6	Anemia 01/2015 - 10/2002
6	Crohn Disease (Crohn's Disease) 01/2013 - 12/2005
6	Alcoholic Liver Diseases (Alcoholic Liver Disease) 03/2008 - 08/2002
5	Fatty Liver 03/2017 - 10/2005
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2012 - 12/2005
4	Hemorrhage 01/2022 - 10/2011
4	Colorectal Neoplasms (Colorectal Cancer) 11/2015 - 08/2002
4	Hypoxia (Hypoxemia) 04/2012 - 09/2005
4	Leukemia 01/2010 - 11/2005
4	Chronic Hepatitis C 09/2009 - 06/2004
3	Liver Cirrhosis (Hepatic Cirrhosis) 05/2018 - 11/2011
3	Neoplasms, Cystic, Mucinous, and Serous 01/2018 - 01/2007
3	Obesity 02/2013 - 09/2007
3	Metaplasia 05/2012 - 02/2006
3	Lymphoma (Lymphomas) 07/2011 - 07/2008
3	Chromosome Aberrations (Chromosome Abnormalities) 03/2011 - 11/2005
3	Adenocarcinoma 12/2010 - 01/2004
2	Disease Progression 12/2020 - 06/2014
2	Breast Neoplasms (Breast Cancer) 01/2019 - 07/2008
2	Hypoalbuminemia 05/2018 - 01/2011
2	Edema (Dropsy) 05/2018 - 01/2011
2	Hemochromatosis (Bronze Diabetes) 03/2017 - 11/2009
2	Ulcerative Colitis 12/2015 - 04/2011
2	Wounds and Injuries (Trauma) 07/2015 - 04/2013
2	Multiple Myeloma 07/2015 - 10/2006
2	Enteritis 07/2015 - 01/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2015 - 11/2006
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2015 - 11/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2014 - 05/2007
2	Acute Promyelocytic Leukemia 06/2014 - 01/2012
2	Disseminated Intravascular Coagulation 01/2014 - 01/2012
2	Carcinoma (Carcinomatosis) 09/2013 - 02/2006

Drug/Important Bio-Agent (IBA)

28	IronIBA 09/2022 - 08/2002
14	Messenger RNA (mRNA)IBA 01/2019 - 07/2002
9	HepcidinsIBA 01/2019 - 11/2005
8	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2008
8	Proteins (Proteins, Gene)FDA Link 07/2015 - 07/2002
7	CytokinesIBA 08/2014 - 09/2002
7	PPAR gammaIBA 06/2006 - 07/2002
6	Transferrin Receptors (Transferrin Receptor)IBA 03/2017 - 08/2002
5	Indicators and Reagents (Reagents)IBA 05/2018 - 05/2011
5	Ferritins (Ferritin)IBA 03/2017 - 10/2002
5	Monoclonal AntibodiesIBA 05/2012 - 02/2006
5	MucinsIBA 10/2011 - 01/2003
5	LigandsIBA 01/2010 - 07/2002
5	Troglitazone (Rezulin)FDA Link 06/2005 - 07/2002
4	Dextrans (Dextran)FDA Link 08/2015 - 11/2011
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 08/2015 - 11/2011
4	Infliximab (Remicade)FDA Link 01/2013 - 12/2005
4	LipidsIBA 11/2012 - 10/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2011 - 09/2005
4	Gemcitabine FDA Link 10/2009 - 03/2004
3	Chelating AgentsIBA 09/2022 - 11/2011
3	Deferasirox FDA Link 09/2022 - 11/2011
3	CollagenIBA 08/2015 - 08/2003
3	Pharmaceutical PreparationsIBA 06/2014 - 11/2006
3	Cadherins (E-Cadherin)IBA 09/2013 - 01/2004
3	Alanine Transaminase (SGPT)IBA 09/2013 - 06/2004
3	SteroidsIBA 04/2011 - 10/2005
3	Dextran SulfateIBA 01/2011 - 04/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 07/2007
3	Peptides (Polypeptides)IBA 01/2010 - 08/2003
3	p38 Mitogen-Activated Protein KinasesIBA 09/2005 - 03/2004
2	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 10/2021 - 12/2020
2	Proton Pump InhibitorsIBA 10/2021 - 12/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2020 - 01/2013
2	Branched-Chain Amino AcidsIBA 05/2018 - 06/2014
2	MicroRNAs (MicroRNA)IBA 01/2018 - 06/2013
2	RNA (Ribonucleic Acid)IBA 03/2017 - 11/2015
2	12,13- dihydro- N- methyl- 6,11,13- trioxo- 5H- benzo(4,5)cyclohepta(1,2- b)naphthalen- 5,12- imineIBA 01/2017 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 07/2016 - 04/2010
2	PolyphosphatesIBA 02/2016 - 08/2015
2	Heterogeneous Nuclear Ribonucleoprotein A1IBA 11/2015 - 07/2015
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2015 - 06/2013
2	Small Interfering RNA (siRNA)IBA 07/2015 - 06/2013
2	AntibodiesIBA 07/2015 - 07/2008
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2014 - 01/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 08/2014 - 09/2007
2	InterferonsIBA 02/2014 - 10/2005
2	Dacarbazine (DIC)FDA LinkGeneric 01/2014 - 01/2012
2	ThrombomodulinIBA 01/2014 - 01/2012
2	Imatinib Mesylate (Gleevec)FDA Link 09/2013 - 11/2005

Therapy/Procedure

22	Therapeutics 09/2020 - 03/2004
8	Drug Therapy (Chemotherapy) 09/2022 - 08/2002
3	Stem Cell Transplantation 06/2014 - 11/2006
2	Chelation Therapy (Therapy, Chelation) 03/2017 - 01/2015
2	Appendectomy 10/2013 - 10/2011